We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News   Jul 06, 2020 | Original story from the World Health Organization (WHO)

 
Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

Credit: Miguel Á. Padriñán, Pexels

 
 
Advertisement
 

RELATED ARTICLES

Washington University COVID-19 Virus Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

Hydrogen Sulfide Reverses Antibiotic Resistance in Some Bacteria

News

A study has found that exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.

READ MORE

New Treatment Regimens Show Early Efficacy Against Drug-Resistant TB

News

New treatment regimens for multidrug-resistant tuberculosis have shown early effectiveness in 85% of patients in a cohort that included many with serious comorbidities.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE